期刊文献+

人S-腺苷蛋氨酸脱羧酶α亚基的克隆、表达与纯化

Cloning,expression and purification of human S-adenosylmethionine decarboxylase gene α subunit
下载PDF
导出
摘要 目的:构建人S-腺苷蛋氨酸脱羧酶(SAMDC)的α亚基的原核表达载体,诱导该质粒在大肠杆菌中表达并纯化表达的重组蛋白。方法:从大肠癌细胞中提取总RNA,RT-PCR方法扩增人SAMDCα亚基的cDNA片段801 bp,经TA克隆及亚克隆方法构建原核表达载体pTriEx-4-SAMDC-α。将重组表达质粒转化入E.coliJM109(DE3)中,经IPTG诱导表达,SDS-PAGE电泳和Western blot鉴定表达蛋白,并通过6×His.Tag,利用亲和层析法纯化表达的融合蛋白。结果:酶切鉴定和DNA测序显示,人SAMDCα亚基的cDNA片段成功插入表达载体pTriEx-4且方向正确,SDS-PAGE电泳显示表达出32kD的外源蛋白。Western blot检测结果显示,表达出的蛋白为6×His.Tag的融合蛋白,且Ni-NTA亲和层析法纯化了该重组蛋白。结论:成功构建、表达且纯化了重组SAMDC-α亚基,为制备抗SAMDC抗体、研究SAMDC基因与结直肠肿瘤的关系提供了必要的工具。 Objective: To construct the prokaryotic expression plasmid of human S-adenosylmethionine decarboxylase (SAMDC) α subunit, and to induce and purify the recombined SAMDC-α protein. Methods: A 801 bp cDNA spanning the coding region of SAMDC α subunit was amplified by RT-PCR and subcloned into prokaryotic expression vector pTriEx-4. The resulted vector pTriEx-4-SAMDC-α was transformed into competence E. coli JM109(DE3), then was induced by IFIG. The protein was verified by SDS-PAGE and Western blot with anti His· Tag monoclonal antibody. The fusion protein including 6 ×His· Tag was purified by Ni-NTA chromatographic column. Results: A 801 bp cDNA was successfully amplified by RT-PCR from colorectal cancer cells and confirmed by sequence. The prokaryotic expression plasmid pTriEx-4-SAMDC-α was successfully constructed, which was identified by digestion and sequence. An approximate 32kDa exogenous protein was observed on the SDS-PAGE and Western blot showed that the protein including 6 × His· Tag was purified successfully by Ni-NTA affinity chromatography. Conclusion: The prokaryotic expression plasmid pTriEx-4-SAMDC-α is constructed correctly and the fusion protein is expressed and purified successfully.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第11期1184-1188,共5页 Journal of Shandong University:Health Sciences
基金 山东省科技厅科技计划项目(032050111)
关键词 S-腺苷蛋氨酸脱羧酶 结直肠肿瘤 原核表达 S-adenosylmethionine decarboxylase(SAMDC) Colorectal neoplasms Prokaryotic expression
  • 相关文献

参考文献17

  • 1Yerlikaya A.Polyamines and S-adenosylmethionine decarboxylase[J].Turk J Biochem,2004,29(2):208-214.
  • 2Hardin MS,Hurta RA.Growth factor-mediated altered expression and regulation of S-adenosylmethionine decarboxylase in a H-Ras transformed cell line capable of malignant progression[J].J Cell Biochem,2002,84(2):349-358.
  • 3Milovic V,Turhanowa L,Fares FA,et al.S-adenosylmethionine decarboxylase activity and utilization of exogenous putrescine are enhanced in colon cancer cells stimulated to grow by EGF[J].Z Gastroenterol,1998,36(11):947-954.
  • 4Wallace HM,Fraser AV,Hughes A.A perspective of polyamine metabolism[J].Biochem J,2003,376(1):1-14.
  • 5Thomas T,Thomas TJ.Polyamines in cell growth and cell death:molecular mechanisms and therapeutic applications[J].Cell Mol Life Sci,2001,58(2):244-258.
  • 6Faaland CA,Thomas TJ,Balabhadrapathruni S,et al.Molecular correlates of the action of bis (ethyl) polyamines in breast cancer cell growth inhibition and apoptosis[ J ].Biochem Cell Biol,2000,78(4):415-426.
  • 7Canizares F,Salinas J,de las Heras M,et al.Prognostic value of ornithine decarboxylase and polyamines in human breast cancer:correlation with clinicopathologic parameters[J].Clin Cancer Res,1999,5(8):2 035-2 041.
  • 8Wallace HM,Caslake R.Polyamines and colon cancer[J].Eur J Gast roenterol Hepatol,2001,13(9):1 033-1 039.
  • 9Naso P,Lanteri R,Acquaviva R,et al.Polyamines levels in colorectal cancer:new markers?[ J].Hepatogastro-enterology,2005,52(62):433-436.
  • 10胡海燕,刘贤锡,姜春英,张岩,王晓明,刘师莲,耿昭,卢翌,张冰,孙爱华.人ODC重组蛋白及其多抗的制备和临床应用[J].中国现代普通外科进展,2004,7(1):26-30. 被引量:3

二级参考文献34

  • 1Giardiello FM, Hamilton SR, Hylind LM, et al. Ornithine decarboxylase and polyamines in familial adenomatous polyposis[J].Cancer Res, 1997,57:199-201.
  • 2Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase as a target for chemoprevention[J]. J Cell Biochem (Suppl.), 1995,22:132-138.
  • 3Bowlin TL,McKnown B,Davis GF,et al. Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice[J]. Cancer Res, 1986,46 : 5494-5498.
  • 4Jeevanandam M,Petersen SR. clinical role of polyamine analysis:problem and promise[J]. Curr Opin Clin Nutr Metab Care,2001,4: 385-390.
  • 5Thomas T, Thomas TJ. Polyamines in cell growth and cell death:molecular mechanisms and therapeutic applications[J].Cell Mol Life Sci ,2001,58:244-258.
  • 6Seiler N, Atanassov CL. Polyamine metabolism as target for cancer chemoprevention (review) [J]. Int J Oncol, 1998, 13:993-1006.
  • 7Kingsnorth AN, Wallace H M. Elevation of monoacetylated polyamines in human breast cancers[J]]. Eur J Cancer Clin Oncol,1985,21:1057-1062.
  • 8Wallace H M, Caslake R. Polyamines and colon cancer[J]. Eur J Gastroenterol Hepatol,2001,13 :1033-1039.
  • 9Faaland CA, Thomas TJ, Balabhadrapathruni S, et al. Molecular correlates of the action of bis (ethyl)polyamines in breast cancer cell growth inhibition and apoptosis[J]]. Biochem Cell Biol,2000,78: 415-426.
  • 10Canizares F,Salinas J,de las Heras M,et al. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer:correlation with clinicopathologic parameters[J]. Clin Cancer Res, 1999,5: 2035-2041.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部